Apatinib Combined With Radiotherapy Enhances Antitumor Effects in an In Vivo Nasopharyngeal Carcinoma Model
Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) are highly expressed in nasopharyngeal carcinoma; therefore, blocking the binding of VEGF and VEGFR may be a potential way to treat nasopharyngeal carcinoma. Apatinib inhibits tumor angiogenesis. Previous studies have suggested that...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2020-05-01
|
| Series: | Cancer Control |
| Online Access: | https://doi.org/10.1177/1073274820922553 |
| _version_ | 1797772308242235392 |
|---|---|
| author | Shanshan Liu MD Fei Wu MD Yanling Zhang MD Rongsheng Qin MD Nengping Zhu MD Yuan Li MD Mingting Wang MD Qin Zeng MD Danna Xie MD Yinghua Li MD Juan Fan MD Yunwei Han PhD |
| author_facet | Shanshan Liu MD Fei Wu MD Yanling Zhang MD Rongsheng Qin MD Nengping Zhu MD Yuan Li MD Mingting Wang MD Qin Zeng MD Danna Xie MD Yinghua Li MD Juan Fan MD Yunwei Han PhD |
| author_sort | Shanshan Liu MD |
| collection | DOAJ |
| description | Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) are highly expressed in nasopharyngeal carcinoma; therefore, blocking the binding of VEGF and VEGFR may be a potential way to treat nasopharyngeal carcinoma. Apatinib inhibits tumor angiogenesis. Previous studies have suggested that treatment with apatinib has an antitumor effect on nasopharyngeal carcinoma. This study will investigate the effect of apatinib combined with radiotherapy. In this study, nude mice injected with CNE-2 nasopharyngeal carcinoma cells were randomly divided into 6 groups. Therapeutic effects were assessed by evaluating tumor inhibition rate, phosphorylation of VEGFR-2, CD31, partial oxygen pressure, and tumor metabolism. We found that the tumor inhibition of mice in the treated groups was better compared to that of the control group. In mice treated with apatinib alone, angiogenesis was prevented, and the tumor tissue partial oxygen pressure was reduced, thereby achieving an antitumor effect. Moreover, the tumor inhibitory effect of combined treatment was stronger than treatment with either apatinib or radiotherapy alone. Compared with monotherapy treatment, combined treatment better resisted angiogenesis. Apatinib combined with radiotherapy to treat nasopharyngeal carcinoma has synergistic effects, which may be related to enhanced antiangiogenesis. |
| first_indexed | 2024-03-12T21:49:14Z |
| format | Article |
| id | doaj.art-730d532c94244858b3b2b9c8cc64ee5a |
| institution | Directory Open Access Journal |
| issn | 1073-2748 |
| language | English |
| last_indexed | 2024-03-12T21:49:14Z |
| publishDate | 2020-05-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Cancer Control |
| spelling | doaj.art-730d532c94244858b3b2b9c8cc64ee5a2023-07-26T06:33:31ZengSAGE PublishingCancer Control1073-27482020-05-012710.1177/1073274820922553Apatinib Combined With Radiotherapy Enhances Antitumor Effects in an In Vivo Nasopharyngeal Carcinoma ModelShanshan Liu MD0Fei Wu MD1Yanling Zhang MD2Rongsheng Qin MD3Nengping Zhu MD4Yuan Li MD5Mingting Wang MD6Qin Zeng MD7Danna Xie MD8Yinghua Li MD9Juan Fan MD10Yunwei Han PhD11 Department of General Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, China Department of Thyroid Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, China Department of Health Management, The Affiliated Hospital of Southwest Medical University, Luzhou, China Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaVascular endothelial growth factor (VEGF) and its receptor (VEGFR) are highly expressed in nasopharyngeal carcinoma; therefore, blocking the binding of VEGF and VEGFR may be a potential way to treat nasopharyngeal carcinoma. Apatinib inhibits tumor angiogenesis. Previous studies have suggested that treatment with apatinib has an antitumor effect on nasopharyngeal carcinoma. This study will investigate the effect of apatinib combined with radiotherapy. In this study, nude mice injected with CNE-2 nasopharyngeal carcinoma cells were randomly divided into 6 groups. Therapeutic effects were assessed by evaluating tumor inhibition rate, phosphorylation of VEGFR-2, CD31, partial oxygen pressure, and tumor metabolism. We found that the tumor inhibition of mice in the treated groups was better compared to that of the control group. In mice treated with apatinib alone, angiogenesis was prevented, and the tumor tissue partial oxygen pressure was reduced, thereby achieving an antitumor effect. Moreover, the tumor inhibitory effect of combined treatment was stronger than treatment with either apatinib or radiotherapy alone. Compared with monotherapy treatment, combined treatment better resisted angiogenesis. Apatinib combined with radiotherapy to treat nasopharyngeal carcinoma has synergistic effects, which may be related to enhanced antiangiogenesis.https://doi.org/10.1177/1073274820922553 |
| spellingShingle | Shanshan Liu MD Fei Wu MD Yanling Zhang MD Rongsheng Qin MD Nengping Zhu MD Yuan Li MD Mingting Wang MD Qin Zeng MD Danna Xie MD Yinghua Li MD Juan Fan MD Yunwei Han PhD Apatinib Combined With Radiotherapy Enhances Antitumor Effects in an In Vivo Nasopharyngeal Carcinoma Model Cancer Control |
| title | Apatinib Combined With Radiotherapy Enhances Antitumor Effects in an In Vivo Nasopharyngeal Carcinoma Model |
| title_full | Apatinib Combined With Radiotherapy Enhances Antitumor Effects in an In Vivo Nasopharyngeal Carcinoma Model |
| title_fullStr | Apatinib Combined With Radiotherapy Enhances Antitumor Effects in an In Vivo Nasopharyngeal Carcinoma Model |
| title_full_unstemmed | Apatinib Combined With Radiotherapy Enhances Antitumor Effects in an In Vivo Nasopharyngeal Carcinoma Model |
| title_short | Apatinib Combined With Radiotherapy Enhances Antitumor Effects in an In Vivo Nasopharyngeal Carcinoma Model |
| title_sort | apatinib combined with radiotherapy enhances antitumor effects in an in vivo nasopharyngeal carcinoma model |
| url | https://doi.org/10.1177/1073274820922553 |
| work_keys_str_mv | AT shanshanliumd apatinibcombinedwithradiotherapyenhancesantitumoreffectsinaninvivonasopharyngealcarcinomamodel AT feiwumd apatinibcombinedwithradiotherapyenhancesantitumoreffectsinaninvivonasopharyngealcarcinomamodel AT yanlingzhangmd apatinibcombinedwithradiotherapyenhancesantitumoreffectsinaninvivonasopharyngealcarcinomamodel AT rongshengqinmd apatinibcombinedwithradiotherapyenhancesantitumoreffectsinaninvivonasopharyngealcarcinomamodel AT nengpingzhumd apatinibcombinedwithradiotherapyenhancesantitumoreffectsinaninvivonasopharyngealcarcinomamodel AT yuanlimd apatinibcombinedwithradiotherapyenhancesantitumoreffectsinaninvivonasopharyngealcarcinomamodel AT mingtingwangmd apatinibcombinedwithradiotherapyenhancesantitumoreffectsinaninvivonasopharyngealcarcinomamodel AT qinzengmd apatinibcombinedwithradiotherapyenhancesantitumoreffectsinaninvivonasopharyngealcarcinomamodel AT dannaxiemd apatinibcombinedwithradiotherapyenhancesantitumoreffectsinaninvivonasopharyngealcarcinomamodel AT yinghualimd apatinibcombinedwithradiotherapyenhancesantitumoreffectsinaninvivonasopharyngealcarcinomamodel AT juanfanmd apatinibcombinedwithradiotherapyenhancesantitumoreffectsinaninvivonasopharyngealcarcinomamodel AT yunweihanphd apatinibcombinedwithradiotherapyenhancesantitumoreffectsinaninvivonasopharyngealcarcinomamodel |